Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Change the future of your lab with Proscia and Concentriq®

Discover the power of our enterprise pathology platform at Booth 200

Book a Meeting

What's Happening at USCAP 2024

Hands-on product demo of Concentriq®

Experience Concentriq® at the Proscia Booth

Meet our team and get a hands-on demo of the Concentriq enterprise pathology platform

Concentriq AP-Dx is our FDA-cleared diagnostic solution (K230839) that immerses pathologists in an intuitive experience for viewing, interpreting, managing, and sharing whole slide images.

Concentriq AP is our comprehensive workflow solution that enables laboratories to achieve 100% digitization and adopt industry-leading AI applications so that they can  deliver faster, more precise results.

PathGroup CMO Derek C. Welch, MD, FCAP

Seminar hosted by Agilent Technologies

One to a Million – Real World Insights of Implementing a Scaled Digital Pathology Workflow

Hear from PathGroup CMO Derek C. Welch, MD, FCAP, about his organization’s visionary journey to digital pathology, and how they are well-positioned for an AI-powered future.

March 25, 2024 | 5:30PM-7:00PM

Leading labs trust Proscia

Proscia’s software is used by forward-thinking laboratories committed to full digitization, and to advance the standard of excellence delivered by the modern pathology lab.

Concentriq AP-Dx

Proscia receives FDA 510(k) clearance for Concentriq® AP-Dx

Proscia’s Concentriq AP-Dx digital pathology solution has been cleared for the purpose of primary diagnosis. Designed to be used in clinical settings of all sizes, from individual reference laboratories to the largest hospital systems, Concentriq AP-Dx offers an intuitive experience for viewing, interpreting, managing, and sharing whole slide images and helps to drive confidence and efficiency gains.


Our website uses cookies. By using this site, you agree to its use of cookies.